id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02660528 | 1:32:chronic_disease, | Active drug or alcohol disorder in the last three months | 2 | [
"Active",
"drug",
"or",
"alcohol",
"disorder",
"in",
"the",
"last",
"three",
"months"
] | [
2,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02347891 | 8:41:treatment,43:57:treatment,59:69:treatment,71:83:treatment,88:109:treatment, | Use of parenteral (IV or IM) antibiotics (antibacterials, antivirals, anti-fungals, or anti parasitic agents) within 60 days of Day | 2 | [
"Use",
"of",
"parenteral",
"(",
"IV",
"or",
"IM",
")",
"antibiotics",
"(",
"antibacterials",
",",
"antivirals",
",",
"anti-fungals",
",",
"or",
"anti",
"parasitic",
"agents",
")",
"within",
"60",
"days",
"of",
"Day"
] | [
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03133013 | 12:22:treatment,38:48:treatment,50:62:treatment,64:71:treatment,73:79:treatment,91:99:treatment | Prescribed interferon regularly with stimulants, opioid drugs (Ritalin, Opioid, etc.) and steroids | 2 | [
"Prescribed",
"interferon",
"regularly",
"with",
"stimulants",
",",
"opioid",
"drugs",
"(",
"Ritalin",
",",
"Opioid",
",",
"etc",
".",
")",
"and",
"steroids"
] | [
0,
1,
0,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1
] |
NCT02114229 | 44:65:treatment,67:80:treatment,85:103:treatment | Requirement for constant administration of proton-pump inhibitor, H2 antagonist, or pancreatic enzymes | 2 | [
"Requirement",
"for",
"constant",
"administration",
"of",
"proton-pump",
"inhibitor",
",",
"H2",
"antagonist",
",",
"or",
"pancreatic",
"enzymes"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
1
] |
NCT02505035 | 1:9:chronic_disease,53:95:treatment,,120:136:treatment, | Dementia admitted from a long-term care facility or prior placement of a surgical feeding tube or 2 or more additional hospitalizations in the past 12 months | 2 | [
"Dementia",
"admitted",
"from",
"a",
"long-term",
"care",
"facility",
"or",
"prior",
"placement",
"of",
"a",
"surgical",
"feeding",
"tube",
"or",
"2",
"or",
"more",
"additional",
"hospitalizations",
"in",
"the",
"past",
"12",
"months"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01915095 | 81:88:chronic_disease | Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold (see appendix 2) | 2 | [
"Receiving",
"drugs",
"acting",
"primarily",
"on",
"the",
"central",
"nervous",
"system",
",",
"which",
"lower",
"the",
"seizure",
"threshold",
"(",
"see",
"appendix",
"2",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02393690 | 19:64:treatment,66:69:treatment,74:88:treatment,117:126:treatment,173:184:allergy_name,186:214:allergy_name,223:239:allergy_name | Prior exposure to mitogen-activated protein kinase kinase (MEK), RAS, or RAF inhibitors (note: previous exposure to sorafenib is allowed) OR history of hypersensitivity to selumetinib, thyrotropin alpha (Thyrogen), or any excipient agents | 2 | [
"Prior",
"exposure",
"to",
"mitogen-activated",
"protein",
"kinase",
"kinase",
"(",
"MEK",
")",
",",
"RAS",
",",
"or",
"RAF",
"inhibitors",
"(",
"note",
":",
"previous",
"exposure",
"to",
"sorafenib",
"is",
"allowed",
")",
"OR",
"history",
"of",
"hypersensit... | [
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4,
4,
0,
0,
0,
0,
0,
4,
4
] |
NCT02593110 | 18:38:treatment | Currently taking aliskiren (Tekturna) | 2 | [
"Currently",
"taking",
"aliskiren",
"(",
"Tekturna",
")"
] | [
0,
0,
1,
1,
0,
0
] |
NCT03045341 | 1:22:chronic_disease | Binge eating disorder (full criteria as described in the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 5th edition) | 2 | [
"Binge",
"eating",
"disorder",
"(",
"full",
"criteria",
"as",
"described",
"in",
"the",
"American",
"Psychiatric",
"Association",
"Diagnostic",
"and",
"Statistical",
"Manual",
"of",
"Mental",
"Disorders",
",",
"5th",
"edition",
")"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697865 | 1:18:chronic_disease | Advanced dementia | 2 | [
"Advanced",
"dementia"
] | [
2,
2
] |
NCT02469129 | 15:21:treatment,42:84:cancer,70:76:cancer,116:127:cancer,181:208:treatment,212:230:treatment,269:276:cancer,278:285:cancer,291:309:cancer | Patients with biopsy-proven diagnosis of head and neck squamous cell cancer (HNSCC) or any histopathologic type of lung cancer or any other type of cancer that can be treated with platinum-based chemotherapy as first-line therapy (which includes but is not limited to ovarian, gastric, and pancreatic cancers) | 2 | [
"Patients",
"with",
"biopsy-proven",
"diagnosis",
"of",
"head",
"and",
"neck",
"squamous",
"cell",
"cancer",
"(",
"HNSCC",
")",
"or",
"any",
"histopathologic",
"type",
"of",
"lung",
"cancer",
"or",
"any",
"other",
"type",
"of",
"cancer",
"that",
"can",
"be",... | [
0,
0,
1,
0,
0,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
3,
0
] |
NCT02479230 | ,,,83:98:cancer | Alkaline phosphatase < 2.5 upper limit of normal (ULN) (< 10 x ULN in presence of bone metastases) | 2 | [
"Alkaline",
"phosphatase",
"<",
"2.5",
"upper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
"(",
"<",
"10",
"x",
"ULN",
"in",
"presence",
"of",
"bone",
"metastases",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT01993810 | 1:19:treatment,47:53:cancer,86:103:treatment | Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields | 2 | [
"Prior",
"radiotherapy",
"to",
"the",
"region",
"of",
"the",
"study",
"cancer",
"that",
"would",
"result",
"in",
"overlap",
"of",
"radiation",
"therapy",
"fields"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02581982 | 21:34:allergy_name,47:57:treatment,59:69:treatment | Hypersensitivity to pembrolizumab, any of its excipients, paclitaxel, or any of its excipients | 2 | [
"Hypersensitivity",
"to",
"pembrolizumab",
",",
"any",
"of",
"its",
"excipients",
",",
"paclitaxel",
",",
"or",
"any",
"of",
"its",
"excipients"
] | [
0,
0,
4,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02594111 | 1:10:chronic_disease | infection (major confounder with increased inflammatory markers) | 2 | [
"infection",
"(",
"major",
"confounder",
"with",
"increased",
"inflammatory",
"markers",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02983903 | 1:13:chronic_disease,,,,, | Coagulopathy (platelet count < 50,000, INR > 1.5) detected on blood testing done within 3 weeks of the procedural visit | 2 | [
"Coagulopathy",
"(",
"platelet",
"count",
"<",
"50,000",
",",
"INR",
">",
"1.5",
")",
"detected",
"on",
"blood",
"testing",
"done",
"within",
"3",
"weeks",
"of",
"the",
"procedural",
"visit"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03178617 | 22:36:cancer,28:36:cancer,43:77:cancer,74:76:cancer,79:107:cancer,,, | Children treated for acute leukemia (e.g. acute lymphoblastic leukemia [ALL], acute myeloid leukemia [AML]), LL, or other types of leukemia (if treated intensively) aged 5-12 years and their parents/caregivers | 2 | [
"Children",
"treated",
"for",
"acute",
"leukemia",
"(",
"e.g",
".",
"acute",
"lymphoblastic",
"leukemia",
"[",
"ALL",
"]",
",",
"acute",
"myeloid",
"leukemia",
"[",
"AML",
"]",
")",
",",
"LL",
",",
"or",
"other",
"types",
"of",
"leukemia",
"(",
"if",
"... | [
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02370056 | 7:22:treatment | total proctocolectomy | 2 | [
"total",
"proctocolectomy"
] | [
0,
1
] |
NCT01983475 | 45:59:treatment,45:60:treatment,,71:81:treatment,,250:259:chronic_disease | Any patient receiving moderate or high dose corticosteroids (>40 mg/d prednisone or an equivalent dose of other corticosteroid) for longer than one week, not including drug administered in an attempt to preserve neurological function at the time of acute SCI | 2 | [
"Any",
"patient",
"receiving",
"moderate",
"or",
"high",
"dose",
"corticosteroids",
"(",
">",
"40",
"mg/d",
"prednisone",
"or",
"an",
"equivalent",
"dose",
"of",
"other",
"corticosteroid",
")",
"for",
"longer",
"than",
"one",
"week",
",",
"not",
"including",
... | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02508038 | 13:42:cancer | Relapsed or primary refractory metastatic | 2 | [
"Relapsed",
"or",
"primary",
"refractory",
"metastatic"
] | [
0,
0,
3,
3,
3
] |
NCT01954316 | 15:27:treatment,29:41:treatment,43:61:treatment,65:90:treatment,,127:138:treatment,142:153:treatment,184:194:treatment,248:264:treatment | Have received radiotherapy, chemotherapy, biological therapy or investigational treatment less than four weeks (six weeks for nitrosourea or mitomycin C) prior to first dose of study medication or have not recovered from all acute toxicities from prior treatments | 2 | [
"Have",
"received",
"radiotherapy",
",",
"chemotherapy",
",",
"biological",
"therapy",
"or",
"investigational",
"treatment",
"less",
"than",
"four",
"weeks",
"(",
"six",
"weeks",
"for",
"nitrosourea",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"first",
"dose",
... | [
0,
0,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02511301 | 10:20:treatment | Previous mastectomy | 2 | [
"Previous",
"mastectomy"
] | [
0,
1
] |
NCT01822522 | 23:42:cancer | The participant has a primary brain tumor | 2 | [
"The",
"participant",
"has",
"a",
"primary",
"brain",
"tumor"
] | [
0,
0,
0,
0,
3,
3,
3
] |
NCT02922569 | 1:14:chronic_disease | schizophrenia | 2 | [
"schizophrenia"
] | [
2
] |
NCT01341080 | ,,83:85:chronic_disease,, | Subjects will have to be at least stage 2 on the Hoehn and Yahr staging system of PD and have a history of at least 1 fall or near fall in the last 6 months | 2 | [
"Subjects",
"will",
"have",
"to",
"be",
"at",
"least",
"stage",
"2",
"on",
"the",
"Hoehn",
"and",
"Yahr",
"staging",
"system",
"of",
"PD",
"and",
"have",
"a",
"history",
"of",
"at",
"least",
"1",
"fall",
"or",
"near",
"fall",
"in",
"the",
"last",
"6"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03073785 | 1:23:cancer,67:81:cancer,90:116:cancer,131:148:chronic_disease,171:186:cancer | T 1-2N+MO or T3-4 NxMo, or borderline resectable and unresectable adenocarcinoma without distant metastatic disease or resectable T3-4 NxMo disease or M1 with controlled distant disease | 2 | [
"T",
"1-2N+MO",
"or",
"T3-4",
"NxMo",
",",
"or",
"borderline",
"resectable",
"and",
"unresectable",
"adenocarcinoma",
"without",
"distant",
"metastatic",
"disease",
"or",
"resectable",
"T3-4",
"NxMo",
"disease",
"or",
"M1",
"with",
"controlled",
"distant",
"diseas... | [
3,
3,
3,
2,
2,
2,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02121158 | ,28:50:chronic_disease | New York Heart Association class IV heart failure | 2 | [
"New",
"York",
"Heart",
"Association",
"class",
"IV",
"heart",
"failure"
] | [
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT03028012 | 1:28:chronic_disease | Gastrointestinal ulceration | 2 | [
"Gastrointestinal",
"ulceration"
] | [
2,
2
] |
NCT02584270 | 36:55:cancer | Patients with a new diagnosis of a T1/T2 tongue cancer | 2 | [
"Patients",
"with",
"a",
"new",
"diagnosis",
"of",
"a",
"T1/T2",
"tongue",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02031250 | 30:40:cancer,48:50:cancer,52:73:cancer,83:111:chronic_disease | Locally/regionally advanced (stage T3‐4 and/or N3) nasopharyngeal cancer which is EBV (‐) (Epstein‐Barr Virus) | 2 | [
"Locally/regionally",
"advanced",
"(",
"stage",
"T3‐4",
"and/or",
"N3",
")",
"nasopharyngeal",
"cancer",
"which",
"is",
"EBV",
"(",
"‐",
")",
"(",
"Epstein‐Barr",
"Virus",
")"
] | [
0,
0,
0,
3,
3,
0,
3,
0,
3,
3,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT01421810 | 10:43:treatment, | Abnormal thyroid stimulating hormone (TSH) for age | 2 | [
"Abnormal",
"thyroid",
"stimulating",
"hormone",
"(",
"TSH",
")",
"for",
"age"
] | [
0,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT02445768 | 67:77:treatment | exhibit contra-indications to enter the magnetic field of the 3T (pacemakers, metal parts in the body etc) | 2 | [
"exhibit",
"contra-indications",
"to",
"enter",
"the",
"magnetic",
"field",
"of",
"the",
"3T",
"(",
"pacemakers",
",",
"metal",
"parts",
"in",
"the",
"body",
"etc",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03043742 | 13:19:cancer, | Untreatable cancer, current or within preceding 5 years | 2 | [
"Untreatable",
"cancer",
",",
"current",
"or",
"within",
"preceding",
"5",
"years"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02388685 | 1:33:treatment | Lower extremity vascular surgery | 2 | [
"Lower",
"extremity",
"vascular",
"surgery"
] | [
1,
1,
1,
1
] |
NCT00929006 | 35:56:chronic_disease,83:107:chronic_disease,109:115:chronic_disease,139:163:treatment | Significant history of cardiac or pulmonary dysfunction (e.g., known or suspected congestive heart failure, asthma requiring intermittent systemic corticosteroids, etc.) | 2 | [
"Significant",
"history",
"of",
"cardiac",
"or",
"pulmonary",
"dysfunction",
"(",
"e.g.",
",",
"known",
"or",
"suspected",
"congestive",
"heart",
"failure",
",",
"asthma",
"requiring",
"intermittent",
"systemic",
"corticosteroids",
",",
"etc",
".",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT01869114 | ,122:131:treatment | Pregnant or lactating patients are ineligible for this study due to the unknown human fetal or teratogenic toxicities of rapamycin | 2 | [
"Pregnant",
"or",
"lactating",
"patients",
"are",
"ineligible",
"for",
"this",
"study",
"due",
"to",
"the",
"unknown",
"human",
"fetal",
"or",
"teratogenic",
"toxicities",
"of",
"rapamycin"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01986075 | 1:28:chronic_disease,78:103:chronic_disease,105:120:chronic_disease,122:143:chronic_disease | Unstable physical disorders which might make participation hazardous such as uncontrolled hypertension, acute hepatitis, uncontrolled diabetes | 2 | [
"Unstable",
"physical",
"disorders",
"which",
"might",
"make",
"participation",
"hazardous",
"such",
"as",
"uncontrolled",
"hypertension",
",",
"acute",
"hepatitis",
",",
"uncontrolled",
"diabetes"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0
] |
NCT01581580 | 1:9:chronic_disease | Dementia as evidenced by formal neuropsychological evaluation | 2 | [
"Dementia",
"as",
"evidenced",
"by",
"formal",
"neuropsychological",
"evaluation"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT02829268 | 10:36:treatment, | received blood product transfusions within 90 days prior to screening | 2 | [
"received",
"blood",
"product",
"transfusions",
"within",
"90",
"days",
"prior",
"to",
"screening"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02543944 | 6:22:chronic_disease,26:42:chronic_disease,53:76:chronic_disease | have major depression or anxiety disorder requiring psychoactive medication (as determined by physician) | 2 | [
"have",
"major",
"depression",
"or",
"anxiety",
"disorder",
"requiring",
"psychoactive",
"medication",
"(",
"as",
"determined",
"by",
"physician",
")"
] | [
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02925923 | 1:7:chronic_disease,, | anemia with HCT<30% | 2 | [
"anemia",
"with",
"HCT",
"<",
"30",
"%"
] | [
2,
0,
0,
0,
0,
0
] |
NCT02783716 | ,84:103:treatment | Patients who are unwilling or unable to return for follow up visits 3 months after device implantation | 2 | [
"Patients",
"who",
"are",
"unwilling",
"or",
"unable",
"to",
"return",
"for",
"follow",
"up",
"visits",
"3",
"months",
"after",
"device",
"implantation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02508311 | ,,,50:60:chronic_disease | Neurological level of injury between T1-T6 (High Paraplegia) | 2 | [
"Neurological",
"level",
"of",
"injury",
"between",
"T1-T6",
"(",
"High",
"Paraplegia",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT03135171 | ,,,89:95:cancer | Eastern Cooperative Oncology Group Performance Status of 0 or 1 (An attempt to quantify cancer patients' general well-being and activities of daily life | 2 | [
"Eastern",
"Cooperative",
"Oncology",
"Group",
"Performance",
"Status",
"of",
"0",
"or",
"1",
"(",
"An",
"attempt",
"to",
"quantify",
"cancer",
"patients",
"'",
"general",
"well-being",
"and",
"activities",
"of",
"daily",
"life"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02437773 | 25:28:chronic_disease | subjects diagnosed with OCD | 2 | [
"subjects",
"diagnosed",
"with",
"OCD"
] | [
0,
0,
0,
2
] |
NCT02436070 | 21:27:chronic_disease | Previous history of asthma as represented in the medical record or by parental report | 2 | [
"Previous",
"history",
"of",
"asthma",
"as",
"represented",
"in",
"the",
"medical",
"record",
"or",
"by",
"parental",
"report"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02479230 | 36:69:treatment | There is no limit to the number of prior systemic treatment regimens | 2 | [
"There",
"is",
"no",
"limit",
"to",
"the",
"number",
"of",
"prior",
"systemic",
"treatment",
"regimens"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT03105362 | 1:30:chronic_disease | microvillus inclusion disease | 2 | [
"microvillus",
"inclusion",
"disease"
] | [
2,
2,
2
] |
NCT02390752 | ,,167:174:treatment | Individuals who are pregnant or breast feeding or who become pregnant while enrolled on this trial will be excluded from participation, due to the unknown effects of PLX3397 on a growing fetus or newborn child | 2 | [
"Individuals",
"who",
"are",
"pregnant",
"or",
"breast",
"feeding",
"or",
"who",
"become",
"pregnant",
"while",
"enrolled",
"on",
"this",
"trial",
"will",
"be",
"excluded",
"from",
"participation",
",",
"due",
"to",
"the",
"unknown",
"effects",
"of",
"PLX3397"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02038257 | 12:26:chronic_disease | History of koebnerization (new patches of vitiligo at sites of injury or trauma) | 2 | [
"History",
"of",
"koebnerization",
"(",
"new",
"patches",
"of",
"vitiligo",
"at",
"sites",
"of",
"injury",
"or",
"trauma",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02367196 | 53:68:chronic_disease | Impaired cardiac function or clinically significant cardiac disease | 2 | [
"Impaired",
"cardiac",
"function",
"or",
"clinically",
"significant",
"cardiac",
"disease"
] | [
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02106650 | 16:42:cancer,53:57:chronic_disease,62:66:cancer,88:97:treatment | diagnosed with hematological malignancies including PTCL and CTCL and are eligible for treatment with a dose of 30 mg/m^2 | 2 | [
"diagnosed",
"with",
"hematological",
"malignancies",
"including",
"PTCL",
"and",
"CTCL",
"and",
"are",
"eligible",
"for",
"treatment",
"with",
"a",
"dose",
"of",
"30",
"mg/m^2"
] | [
0,
0,
3,
3,
0,
2,
0,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02421341 | ,80:116:chronic_disease | Will be matched for age, gender, height and weight and will have no history of cardiovascular related abnormalities | 2 | [
"Will",
"be",
"matched",
"for",
"age",
",",
"gender",
",",
"height",
"and",
"weight",
"and",
"will",
"have",
"no",
"history",
"of",
"cardiovascular",
"related",
"abnormalities"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02925923 | 1:14:treatment | Telithormycin | 2 | [
"Telithormycin"
] | [
1
] |
NCT02278367 | 18:21:treatment,,, | Have a screening ECG with QTc > 450 msec if male | 2 | [
"Have",
"a",
"screening",
"ECG",
"with",
"QTc",
">",
"450",
"msec",
"if",
"male"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01823198 | 46:71:treatment | Failed to achieve a cytogenetic remission to tyrosine kinase inhibitor treatment or has a cytogenetic relapse | 2 | [
"Failed",
"to",
"achieve",
"a",
"cytogenetic",
"remission",
"to",
"tyrosine",
"kinase",
"inhibitor",
"treatment",
"or",
"has",
"a",
"cytogenetic",
"relapse"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02792257 | 13:20:chronic_disease | Presence of Agit-AD as defined by the provisional criteria from the International Psychogeriatric Association (IPA) | 2 | [
"Presence",
"of",
"Agit-AD",
"as",
"defined",
"by",
"the",
"provisional",
"criteria",
"from",
"the",
"International",
"Psychogeriatric",
"Association",
"(",
"IPA",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02133898 | 1:14:chronic_disease | Schizophrenia | 2 | [
"Schizophrenia"
] | [
2
] |
NCT02861950 | 28:45:chronic_disease | abnormal caudal anatomy or spinal dysraphism | 2 | [
"abnormal",
"caudal",
"anatomy",
"or",
"spinal",
"dysraphism"
] | [
0,
0,
0,
0,
2,
2
] |
NCT01893554 | 20:43:treatment,47:67:treatment,,100:127:treatment | Receipt of another investigational vaccine or investigational drug 28 days prior to receiving this investigational RSV vaccine | 2 | [
"Receipt",
"of",
"another",
"investigational",
"vaccine",
"or",
"investigational",
"drug",
"28",
"days",
"prior",
"to",
"receiving",
"this",
"investigational",
"RSV",
"vaccine"
] | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02574650 | 10:47:treatment | Previous tricuspid valve repair or replacement | 2 | [
"Previous",
"tricuspid",
"valve",
"repair",
"or",
"replacement"
] | [
0,
1,
1,
1,
1,
1
] |
NCT02257424 | 30:50:treatment | Any number and type of prior anticancer therapies | 2 | [
"Any",
"number",
"and",
"type",
"of",
"prior",
"anticancer",
"therapies"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02535832 | 16:18:chronic_disease | Diagnosed with RA by a Rheumatologist and according to American College of Rheumatology 2010 criteria | 2 | [
"Diagnosed",
"with",
"RA",
"by",
"a",
"Rheumatologist",
"and",
"according",
"to",
"American",
"College",
"of",
"Rheumatology",
"2010",
"criteria"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02320292 | 1:36:chronic_disease | Hepatitis B surface antigen (HBsAg) positive | 2 | [
"Hepatitis",
"B",
"surface",
"antigen",
"(",
"HBsAg",
")",
"positive"
] | [
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT02329652 | 1:43:chronic_disease | diabetes with peripheral nerve involvement | 2 | [
"diabetes",
"with",
"peripheral",
"nerve",
"involvement"
] | [
2,
2,
2,
2,
2
] |
NCT02406885 | 41:49:allergy_name | History of hypersensitivity reaction to apixaban | 2 | [
"History",
"of",
"hypersensitivity",
"reaction",
"to",
"apixaban"
] | [
0,
0,
0,
0,
0,
4
] |
NCT02520713 | 1:43:cancer | Infantile fibrosarcoma without NTRK fusion | 2 | [
"Infantile",
"fibrosarcoma",
"without",
"NTRK",
"fusion"
] | [
3,
3,
3,
3,
3
] |
NCT02261857 | 23:27:treatment | Inability to tolerate CPAP attributed to poor fit by a sleep clinician | 2 | [
"Inability",
"to",
"tolerate",
"CPAP",
"attributed",
"to",
"poor",
"fit",
"by",
"a",
"sleep",
"clinician"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03153982 | 8:25:treatment,84:95:treatment,127:137:treatment,139:153:treatment,155:165:treatment,167:176:treatment,178:190:treatment,192:204:treatment,206:215:treatment,217:227:treatment,229:239:treatment,241:251:treatment,253:265:treatment,267:276:treatment,278:288:treatment,290:300:treatment,302:315:treatment,320:332:treatment | Strong CYP3A4 inhibitors: (Patients must discontinue drug 7 days prior to starting ruxolitinib), including but not limited to boceprevir, clarithromycin, conivaptan, indinavir, itraconazole, ketoconazole, lopinavir, mibefradil, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir, telaprevir, telithromycin, or v... | 2 | [
"Strong",
"CYP3A4",
"inhibitors",
":",
"(",
"Patients",
"must",
"discontinue",
"drug",
"7",
"days",
"prior",
"to",
"starting",
"ruxolitinib",
")",
",",
"including",
"but",
"not",
"limited",
"to",
"boceprevir",
",",
"clarithromycin",
",",
"conivaptan",
",",
"in... | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02312570 | ,,,106:123:treatment,125:137:treatment,139:164:treatment,168:183:treatment, | WBC >13,000/cm3 or < 5, 000 cm3, or electrolytes that are outside the host institution's range of normal Radiation therapy, chemotherapy, immunosuppressive therapy or chronic steroid use within 30 days of enrollment | 2 | [
"WBC",
">",
"13,000/cm3",
"or",
"<",
"5",
",",
"000",
"cm3",
",",
"or",
"electrolytes",
"that",
"are",
"outside",
"the",
"host",
"institution",
"'s",
"range",
"of",
"normal",
"Radiation",
"therapy",
",",
"chemotherapy",
",",
"immunosuppressive",
"therapy",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01614197 | 16:23:chronic_disease | No evidence of dyspnea at rest and no exercise intolerance | 2 | [
"No",
"evidence",
"of",
"dyspnea",
"at",
"rest",
"and",
"no",
"exercise",
"intolerance"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02466009 | 12:30:chronic_disease | Measurable metastatic disease | 2 | [
"Measurable",
"metastatic",
"disease"
] | [
0,
2,
2
] |
NCT02167009 | ,60:89:treatment | Patient has a prostate size larger than 90g as measured by transrectal ultrasound (TRUS) | 2 | [
"Patient",
"has",
"a",
"prostate",
"size",
"larger",
"than",
"90g",
"as",
"measured",
"by",
"transrectal",
"ultrasound",
"(",
"TRUS",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT02497300 | 1:25:chronic_disease,, | Diabetes mellitus type 2 with glycosylated hemoglobin ≥ 6.5% | 2 | [
"Diabetes",
"mellitus",
"type",
"2",
"with",
"glycosylated",
"hemoglobin",
"≥",
"6.5",
"%"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02459119 | 1:14:chronic_disease,25:29:treatment,33:52:treatment | Renal failure requiring hemo-or peritoneal dialysis | 2 | [
"Renal",
"failure",
"requiring",
"hemo-or",
"peritoneal",
"dialysis"
] | [
2,
2,
0,
1,
1,
1
] |
NCT02561104 | 1:9:chronic_disease | Hypotony | 2 | [
"Hypotony"
] | [
2
] |
NCT01823198 | 1:31:cancer | Chronic myeloid leukemia (CML) | 2 | [
"Chronic",
"myeloid",
"leukemia",
"(",
"CML",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02237183 | 47:66:cancer, | Participants must not have a current or prior invasive malignancy within the past 6 months | 2 | [
"Participants",
"must",
"not",
"have",
"a",
"current",
"or",
"prior",
"invasive",
"malignancy",
"within",
"the",
"past",
"6",
"months"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT02577406 | 1:30:chronic_disease | acute coronary syndrome (ACS) | 2 | [
"acute",
"coronary",
"syndrome",
"(",
"ACS",
")"
] | [
2,
2,
2,
2,
0,
0
] |
NCT03123055 | 32:61:chronic_disease,63:83:chronic_disease,98:109:chronic_disease,111:133:chronic_disease | Participants with a history of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on the Screening chest CT scan | 2 | [
"Participants",
"with",
"a",
"history",
"of",
"idiopathic",
"pulmonary",
"fibrosis",
",",
"organizing",
"pneumonia",
",",
"drug-induced",
"pneumonitis",
",",
"idiopathic",
"pneumonitis",
",",
"or",
"evidence",
"of",
"active",
"pneumonitis",
"on",
"the",
"Screening",... | [
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02603757 | 27:52:treatment, | Patients taking high-dose Vitamin D supplementation (50,000 IU weekly) prior to enrollment | 2 | [
"Patients",
"taking",
"high-dose",
"Vitamin",
"D",
"supplementation",
"(",
"50,000",
"IU",
"weekly",
")",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02479906 | 12:36:chronic_disease | History of cerebrovascular accident | 2 | [
"History",
"of",
"cerebrovascular",
"accident"
] | [
0,
0,
2,
2
] |
NCT01522768 | 61:70:treatment | Known or suspected active drug or alcohol abuse. Restricted Therapies | 2 | [
"Known",
"or",
"suspected",
"active",
"drug",
"or",
"alcohol",
"abuse",
".",
"Restricted",
"Therapies"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02112617 | 32:44:treatment,,99:116:treatment,197:222:treatment | Patients will be ineligible if chemotherapy was completed ≥ 1 year from the planned start date of radiation therapy or if the patient is referred for radiation therapy after a relapse following a regimen with chemotherapy alone | 2 | [
"Patients",
"will",
"be",
"ineligible",
"if",
"chemotherapy",
"was",
"completed",
"≥",
"1",
"year",
"from",
"the",
"planned",
"start",
"date",
"of",
"radiation",
"therapy",
"or",
"if",
"the",
"patient",
"is",
"referred",
"for",
"radiation",
"therapy",
"after",... | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT02464878 | 8:28:chronic_disease | Active peptic ulcer disease | 2 | [
"Active",
"peptic",
"ulcer",
"disease"
] | [
0,
2,
2,
2
] |
NCT02358681 | 60:70:treatment, | Frequent use of drugs for headache (i.e. regular intake of analgesics for acute headaches on more than 10 days per month) | 2 | [
"Frequent",
"use",
"of",
"drugs",
"for",
"headache",
"(",
"i.e",
".",
"regular",
"intake",
"of",
"analgesics",
"for",
"acute",
"headaches",
"on",
"more",
"than",
"10",
"days",
"per",
"month",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02397083 | 42:54:allergy_name | Known intolerance or hypersensitivity to progesterone or its excipients | 2 | [
"Known",
"intolerance",
"or",
"hypersensitivity",
"to",
"progesterone",
"or",
"its",
"excipients"
] | [
0,
0,
0,
0,
0,
4,
0,
0,
0
] |
NCT03105700 | 1:14:chronic_disease | schizophrenia | 2 | [
"schizophrenia"
] | [
2
] |
NCT02042222 | 70:89:treatment | A decision by the subject's family and primary clinician to initiate hydroxyurea therapy, made independently of recruitment for the study (not applicable for the biological arm patients) | 2 | [
"A",
"decision",
"by",
"the",
"subject",
"'s",
"family",
"and",
"primary",
"clinician",
"to",
"initiate",
"hydroxyurea",
"therapy",
",",
"made",
"independently",
"of",
"recruitment",
"for",
"the",
"study",
"(",
"not",
"applicable",
"for",
"the",
"biological",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01966367 | 10:24:chronic_disease | Adequate renal function as determined by the institutional normal range | 2 | [
"Adequate",
"renal",
"function",
"as",
"determined",
"by",
"the",
"institutional",
"normal",
"range"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02469662 | 61:70:chronic_disease | Patient has a currently active or history of repeated local infection at the surgical site | 2 | [
"Patient",
"has",
"a",
"currently",
"active",
"or",
"history",
"of",
"repeated",
"local",
"infection",
"at",
"the",
"surgical",
"site"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02215096 | 1:24:treatment,, | Investigational drug(s) within 30 days or 5 half-lives, whichever is longer, prior to enrollment | 2 | [
"Investigational",
"drug",
"(",
"s",
")",
"within",
"30",
"days",
"or",
"5",
"half-lives",
",",
"whichever",
"is",
"longer",
",",
"prior",
"to",
"enrollment"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01366612 | ,,,,55:86:treatment | FVC, FEV1, or DLCO <50% of predicted and/or receiving supplementary continuous oxygen | 2 | [
"FVC",
",",
"FEV1",
",",
"or",
"DLCO",
"<",
"50",
"%",
"of",
"predicted",
"and/or",
"receiving",
"supplementary",
"continuous",
"oxygen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01553942 | 27:35:allergy_name,37:46:allergy_name,51:61:allergy_name | Known hypersensitivity to afatinib, cisplatin, or pemetrexed | 2 | [
"Known",
"hypersensitivity",
"to",
"afatinib",
",",
"cisplatin",
",",
"or",
"pemetrexed"
] | [
0,
0,
0,
4,
0,
4,
0,
0,
4
] |
NCT02956486 | 13:33:chronic_disease,85:111:treatment,115:139:treatment | Any chronic inflammatory disease that is not adequately controlled or that requires systemic immunosuppressive or immunomodulatory therapy | 2 | [
"Any",
"chronic",
"inflammatory",
"disease",
"that",
"is",
"not",
"adequately",
"controlled",
"or",
"that",
"requires",
"systemic",
"immunosuppressive",
"or",
"immunomodulatory",
"therapy"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1
] |
NCT02924441 | 1:15:treatment | breast surgery | 2 | [
"breast",
"surgery"
] | [
1,
1
] |
NCT01174121 | 24:49:treatment | Refractory to approved standard systemic therapy | 2 | [
"Refractory",
"to",
"approved",
"standard",
"systemic",
"therapy"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02791646 | ,52:58:cancer | current or past (<6 months) engagement in PCST for cancer | 2 | [
"current",
"or",
"past",
"(",
"<",
"6",
"months",
")",
"engagement",
"in",
"PCST",
"for",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02437370 | 11:36:treatment,,, | Has had a prior monoclonal antibody within 4 weeks prior to study day 1 or who has not recovered (i.e., =< grade 1 or at baseline) from adverse events due to agents administered more than 4 weeks earlier | 2 | [
"Has",
"had",
"a",
"prior",
"monoclonal",
"antibody",
"within",
"4",
"weeks",
"prior",
"to",
"study",
"day",
"1",
"or",
"who",
"has",
"not",
"recovered",
"(",
"i.e.",
",",
"=",
"<",
"grade",
"1",
"or",
"at",
"baseline",
")",
"from",
"adverse",
"events"... | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03033212 | 1:28:chronic_disease | intervertebral disc disease | 2 | [
"intervertebral",
"disc",
"disease"
] | [
2,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.